
Aptose Biosciences (APTO) Latest News & Updates
Explore latest Aptose Biosciences (APTO) News and Updates
Stay updated on Aptose Biosciences (APTO) with the latest news, market trends, and key developments to support informed investing decisions.
Start investing in Aptose Biosciences (APTO)
Order type
Buy in
Order amount
Est. shares
0 shares
GlobeNewsWire •



GlobeNewsWire •



GlobeNewsWire •

GlobeNewsWire •


Aptose Announces First AML Patients Dosed with Tuspetinib Triplet Frontline Therapy in TUSCANY Trial
GlobeNewsWire •

GlobeNewsWire •



GlobeNewsWire •



GlobeNewsWire •

GlobeNewsWire •




GlobeNewsWire •

GlobeNewsWire •

GlobeNewsWire •

Zacks Investment Research •
